<table border="1"><tr><th>Freiname</th><td>Etravirin</td></tr><tr><th>Andere Namen</th><td>4-[6-Amino-5-brom-2-(4-cyanophenylamino)pyrimidin-4-yloxy]-3,5-dimethylbenzonitril (IUPAC) | TMC-125</td></tr><tr><th>Summenformel</th><td>C | 20 | H | 15 | BrN | 6 | O</td></tr><tr><th>EG-Nummer</th><td>682-331-6</td></tr><tr><th>ECHA-InfoCard</th><td>100.207.546</td></tr><tr><th>PubChem</th><td>193962</td></tr><tr><th>ChemSpider</th><td>168313</td></tr><tr><th>DrugBank</th><td>DB06414</td></tr><tr><th>Wikidata</th><td>Q414762</td></tr><tr><th>ATC-Code</th><td>J05 | AG04</td></tr><tr><th>Wirkstoffklasse</th><td>Virustatikum, nichtnukleosidische Reverse-Transkriptase-Inhibitoren</td></tr><tr><th>Wirkmechanismus</th><td>nicht-kompetitive Hemmung der reversen Transkriptase</td></tr><tr><th>Molare Masse</th><td>435,28 g·mol | −1</td></tr><tr><th>GHS-Gefahrstoffkennzeichnung | Achtung</th><td></td></tr><tr><th>H- und P-Sätze</th><td>H | 302 |  ‐ | 413</td></tr></table>